Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
Cell|August 12, 2006
Clonal origin and evolution of a transmissible cancerClaudio Murgia, Jonathan K Pritchard, Su Yeon Kim, et al.
AIDS (London, England)|January 31, 2003
CD4-dependent and CD4-independent HIV-2: consequences for neutralizationElaine R Thomas, Christine Shotton, Robin A Weiss, et al.
Oncoimmunology|May 4, 2016
Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune responseJessie Thalmensi, Elodie Pliquet, Christelle Liard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
Universal cancer peptide-based therapeutic vaccine breaks tolerance against telomerase and eradicates established tumorMagalie Dosset, Yann Godet, Charline Vauchy, et al.
Oncotarget|June 6, 2019
A DNA telomerase vaccine for canine cancer immunotherapyJessie Thalmensi, Elodie Pliquet, Christelle Liard, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2003
Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profileRichard G Jenner, Karine Maillard, Nicola Cattini, et al.
The Journal of General Virology|August 30, 2008
Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparisonEdward Wright, Nigel J Temperton, Denise A Marston, et al.
Retrovirology|February 21, 2015
Neutralisation of HIV-1 cell-cell spread by human and llama antibodiesLaura E McCoy, Elisabetta Groppelli, Christophe Blanchetot, et al.
Emerging Infectious Diseases|March 11, 2005
Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypesNigel J Temperton, Paul K Chan, Graham Simmons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid TumorsLuis Teixeira, Jacques Medioni, Julie Garibal, et al.
Pageof 16